We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+1.51%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.37B
AUM Growth
-$153M
Cap. Flow
-$172M
Cap. Flow %
-7.27%
Top 10 Hldgs %
14.27%
Holding
746
New
211
Increased
117
Reduced
165
Closed
240

Sector Composition

Rank Sector Weight
1 Real Estate 16.64%
2 Industrials 9.86%
3 Consumer Discretionary 9.49%
4 Technology 7.68%
5 Energy 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBR
451
DELISTED
CyberArk
CYBR
$483K 0.02%
9,672
-10,328
-52% -$522K
PRTK
452
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$482K 0.02%
20,000
+10,000
+100% +$221K
BECN
453
DELISTED
Beacon Roofing Supply, Inc.
BECN
$474K 0.02%
9,672
-110,655
-92% -$5.44M
VXX
454
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$472K 0.02%
9,250
+6,500
+236% +$376K
IMPV
455
DELISTED
Imperva, Inc.
IMPV
$463K 0.02%
9,672
-15,328
-61% -$715K
KERX
456
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$463K 0.02%
64,000
-1,000
-2% -$6.25K
ECHO
457
DELISTED
Echo Global Logistics, Inc.
ECHO
$462K 0.02%
23,203
-26,797
-54% -$521K
PG icon
458
Procter & Gamble
PG
$343B
$458K 0.02%
5,251
-65,865
-93% -$5.81M
WAB icon
459
Wabtec
WAB
$51.1B
$458K 0.02%
5,000
-80,016
-94% -$6.67M
ADAP
460
DELISTED
Adaptimmune Therapeutics
ADAP
$453K 0.02%
101,000
-9,000
-8% -$47K
DPLO
461
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$444K 0.02%
30,000
+20,000
+200% +$333K
PETX
462
DELISTED
Aratana Therapeutics, Inc.
PETX
$434K 0.02%
60,000
-5,000
-8% -$30.7K
CPB icon
463
PUT
Campbell Soup
CPB
$6.51B
$417K 0.02%
+8,000
New +$453K
AXS icon
464
AXIS Capital
AXS
$8.59B
$414K 0.02%
+6,400
New +$417K
BY icon
465
Byline Bancorp
BY
$1.75B
$401K 0.02%
+20,000
New +$401K
NAT icon
466
PUT
Nordic American Tanker
NAT
$1.37B
$396K 0.02%
+63,000
New +$443K
WMGI
467
DELISTED
Wright Medical Group Inc
WMGI
$385K 0.02%
14,000
LAB icon
468
Standard BioTools
LAB
$326M
$384K 0.02%
95,000
-5,000
-5% -$23.7K
PACB icon
469
Pacific Biosciences
PACB
$422M
$379K 0.02%
106,500
-500
-0.5% -$2.02K
ARGX icon
470
argenx
ARGX
$57.4B
$371K 0.02%
+17,500
New +$364K
AGEN
471
Agenus
AGEN
$249M
$352K 0.01%
4,585
-51
-1% -$3.59K
GCP
472
DELISTED
GCP Applied Technologies Inc.
GCP
$342K 0.01%
11,213
-102
-0.9% -$3.21K
QURE icon
473
uniQure
QURE
$2.68B
$334K 0.01%
54,000
-1,000
-2% -$5.4K
AMG icon
474
Affiliated Managers Group
AMG
$9.46B
$321K 0.01%
1,938
-545
-22% -$87K
TROW icon
475
T. Rowe Price
TROW
$25B
$320K 0.01%
+4,308
New +$308K

Similar funds

Weiss Multi-Strategy Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, Weiss Multi-Strategy Advisers held 746 positions worth $2.37B, down 6.1% from $2.52B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Weiss Multi-Strategy Advisers withdrew a net $172M in Q2 2017, closing 240 positions and reducing 165 holdings. Its most notable exit was New York REIT, Inc., an estimated $38.8M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, down from 22% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Weiss Multi-Strategy Advisers opened a new position in Hudson Pacific Properties worth $47.8M.

  • Weiss Multi-Strategy Advisers's largest Q2 2017 buy was Hudson Pacific Properties: 199,673 shares worth $47.8M.
  • Weiss Multi-Strategy Advisers added most to Liberty Property Trust in Q2 2017, an estimated $31.8M increase.
  • Weiss Multi-Strategy Advisers's biggest Q2 2017 reduction was Veris Residential, cutting an estimated $24.8M.
  • Weiss Multi-Strategy Advisers fully exited New York REIT, Inc. in Q2 2017, selling an estimated $38.8M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 14% of its $2.37B portfolio in Q2 2017.
  • Weiss Multi-Strategy Advisers opened 211 new positions and closed 240 in Q2 2017.
  • Weiss Multi-Strategy Advisers's portfolio value fell 6.1% quarter-over-quarter to $2.37B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2017, filed 14 Aug 2017.